Our residents make research presentations at annual meetings and international radiation oncology societies. In addition, many of our residents have received grants and awards for their work.
-
Gustav Cederquist, MD, PhD
- Patterns of Intracranial Response and Relapse after Radiotherapy for Patients with Chemorefractory or Progressive Secondary CNS Lymphoma
-
Christopher Jackson, MD
- Risk of Radiation Myelitis after Hypofractionated Spine Stereotactic Body Radiation Therapy
- The Effect of Histology and Delivered Dose on Local Failure Rates with Three-Fraction Spine SBRT
- Reduced-Dose Radiation Therapy for High-Risk Neuroblastoma: Results from a Prospective Clinical Trial
-
Matthew McMillan, MD
- The Impact of the Time of Day of Radiotherapy and Systemic Therapy on Disease Control in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation and Durvalumab
- A Phase II Trial of Hepatic Ablation of Metastases to Modulate and Enhance Immunotherapy Response (HAMMER) in Non-Small Cell Lung Cancer
-
Edward Christopher Dee, MD
- Nasopharynx cancer in the US: disparities in stage at presentation
- Nasopharynx Cancer in Southeast Asia: An Analysis of 2022 Incidence and Mortality
-
Nikhil Mankuzhy, MD
- Nasal Cavity Malignancies Treated with Definitive Proton Therapy: A Single Institution’s Experience
-
Kaitlyn Lapen, MD
- Transportation Insecurity among Patients with Cancer Undergoing Radiation Therapy
-
Alexandra Dreyfuss, MD
- Failure patterns by PET for relapsed/refractory Multiple Myeloma (r/r MM) after CAR T cell therapy: Potential for radiotherapy (RT)?
- Early experience with salvage RT for relapsed/refractory Multiple Myeloma following BCMA-directed CART cell therapy.
- Radiation therapy (RT) in a new era of Multiple Myeloma (MM) management: Trends of engagement and radiologic, biochemical, and cytogenetic correlates of outcomes and response.
-
Alexander Goglia, MD, PhD
- Prognostic Implications of Cerebrospinal Fluid Circulating Tumor DNA (CSF ctDNA) Following Radiation Therapy in Patients with Leptomeningeal Metastasis: Analysis of a Randomized Phase II Trial
-
Shoshana Rosenzweig, MD
- Impact of Adjuvant Radiation on Mortality in Surgically Staged Stage IB Grade 3 and II Endometrioid Endometrial Cancer: Propensity Score Matching Analysis
-
David Miller, MD
- Dosimetric Results for Organs at Risk (OAR) from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer (HPV+ OPC): A Retrospective Analysis
-
Chris Jackson
Treatment of Thymic Oligometastastic or Oligoprogressive Lesions with Hypofractionated Radiation Therapy or Stereotactic Body Radiation Therapy -
Chengcheng Gui:
Serum Tumor Marker Response Predicts Survival and Intracranial Control after Radiation Therapy for Germ Cell Tumor Brain Metastases
-
Christopher Jackson:
- 2024 ASTRO Annual Meeting Abstract Award
- 2024 Children’s Oncology Group Radiation Oncology Young Investigator Abstract Award
- ASCO Conquer Cancer Merit Award (Eisai Inc. Endowed Merit Award)
-
Edward (Christopher) Dee:
- ASCO 2023 Conquer Cancer Merit Award
-
Alexander Goglia:
- 2024 ASTRO Annual Meeting Abstract Award
- NIH LRP Grant
-
Gustav Cederquist
- 2023 ASTRO Resident Seed Grant
- 2023 ASH Abstract Achievement Award
-
Kevin Boehm
- Major Grant, The Fund for Innovation in Cancer Informatics